Miguel Gavino

BTI Biotechnology Institute

BTI Biotechnology Institute is a Spanish multinational company specialising in biomedicine and biotechnology whose activity focuses on two areas: regenerative medicine and oral implantology. It was founded in 1999 by Dr. Eduardo Anitua, the company's president and scientific director. Oral Implantology: BTI's implant system is one of the most versatile on the market, an implant system that adapts to the patient, not the other way around, as it offers an extremely wide range of solutions tailored to each need, so that dental professionals can approach their treatments with the utmost confidence and predictability. Regenerative Medicine: BTI is a scientific world leader in regenerative medicine as a result of the development and patenting of Plasma Rich in Growth Factors (Endoret® (PRGF®)) technology and its various applications in multiple fields of medicine such as oral and maxillofacial surgery, trauma, dermatology, rheumatology, ophthalmology, sports medicine and cosmetic medicine. Research is the DNA of BTI: BTI is a company highly focused on the research and development of new solutions in the area of biomedicine. The research carried out has a clear translational component, seeking to apply the knowledge acquired in the laboratory to daily clinical practice, with the aim of improving patient care and quality of life. Training is one of the cornerstones: The Postgraduate and Training Centre in Vitoria has become established as a leading international centre for oral implantology and regenerative therapy, which provides training to 2,000 students of various nationalities each year. The wide range of courses on offer includes our continuous training programmes, specialised courses, residential courses, conferences and symposiums.